secwatch.observer — SEC 8-K summary
======================================

Issuer:     PMV Pharmaceuticals, Inc. (PMVP)
CIK:        0001699382
Form:       8-K
Filed at:   2024-06-07T23:59:59+00:00
Accession:  0001193125-24-156745
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

PMV Pharma shareholders elect directors, approve say-on-pay, ratify auditor at 2024 annual meeting
--------------------------------------------------------------------------------

- Class I directors Kirsten Flowers and Carol Gallagher elected with 35.7M and 27.1M votes for, respectively.
- Non-binding advisory vote on executive compensation approved: 34.5M for, 1.1M against, 0.8M abstain.
- Ratification of Ernst & Young as independent auditor for FY2024 passed with 43.5M for, 90.9K against.
- Broker non-votes: 7.2M on director elections and say-on-pay proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1699382/000119312524156745/0001193125-24-156745-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1699382/000119312524156745/d850099d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-156745

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer